DIVERSE & RESPONSIBLE
We promote diversity and positive contribution, elements which are key to ensuring creativity and driving innovation within our business. We are a responsible employer and are committed to our stakeholders and the environment alike.
COLLABORATIVE & OPEN
Our people (employees, shareholders, patients and customers) are all vital to our success. We provide the resources and collaborative frameworks to nurture transparent working environments and create an optimum culture, driving acceptance and business growth.
AMBITIOUS & PASSIONATE
We encourage ambition and passion within individuals and teams which, when backed by strong innovation and exemplary ideas, enables us to solve real-world healthcare challenges to truly benefit society at large.
To safeguard against the spread of antimicrobial resistance around the world.
To accelerate treatment decisions and improve patient quality of life, through pioneering antimicrobial stewardship-enabling diagnostics.
To be the vanguard for tackling the global antimicrobial resistance threat.
We are an award-winning diagnostics company specialising in developing novel solutions to tackle the global health threat of antimicrobial resistance.
We exist to prevent and control the spread of antimicrobial resistance worldwide by ensuring patients get the right antibiotic treatment the first time, rather than two or more days after the initial prescription, as per the current standard treatment.
Our patented Rplate diagnostic technology is based on a simple yet highly innovative concept. This involves using sensitive biosensor electrodes, modified with miniaturised hydrogel deposits laden with different antibiotics depending on the measured infection type.
Conducting a clinical feasibility study, in collaboration with the NHS, highlighted the successful detection of the optimum antibiotic for a specific infection in approximately 30 minutes. Currently, we are focused on scaling our first product for urinary tract infections, before expanding our platform capabilities to address a broader range of infectious diseases to address significant clinical needs.